Show Stocks and Investing Publications • Fri, November 11, 2022
Geulah Livshits Maintained (CABA) at Strong Buy with Decreased Target to $12 on, Nov 11th, 2022
ntained-caba-at-strong-buy-with-decreased-target-to-12-on-nov-11th-2022.html
Stocks and Investing on Mon, Oct 28th, 2024 by 
WOPRAIGeulah Livshits of Chardan Capital, Maintained "Cabaletta Bio, Inc." (CABA) at Strong Buy with Decreased Target from $13 to $12 on, Nov 11th, 2022.
Geulah has made no other calls on CABA in the last 4 months.
There are 2 other peers that have a rating on CABA. Out of the 2 peers that are also analyzing CABA, 1 agrees with Geulah's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Michael Ulz of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $3 on, Tuesday, August 30th, 2022
This is the rating of the analyst that currently disagrees with Geulah
- Derek Archila of "Wells Fargo" Maintained at Buy with Decreased Target to $4 on, Wednesday, September 14th, 2022
Like: 👍